One of the state pharmaceutical companies, partially privatized on the stock exchange. Manufacturing of cosmetics & 56 pharmaceutical lines, with exports to Middle Eastern, African & Eastern European markets. Highest market share among public companies. Plans to open Middle East's first genetic engineering facility to produce specialty drugs. Plans for manufacturing TAMONILE for birds flu treatment. Negotiating with Sanofi Aventis to obtain 5 new licenses. Expanding its activity with 3 new production lines in beverages. 101250000 EGP 101250000 EGP 500000000 EGP 450579086 EGP 115668 Cairo 0001967 107M Joint Stock Public